DK1363633T3 - Vådgranulerings-fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat - Google Patents

Vådgranulerings-fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat

Info

Publication number
DK1363633T3
DK1363633T3 DK02700190T DK02700190T DK1363633T3 DK 1363633 T3 DK1363633 T3 DK 1363633T3 DK 02700190 T DK02700190 T DK 02700190T DK 02700190 T DK02700190 T DK 02700190T DK 1363633 T3 DK1363633 T3 DK 1363633T3
Authority
DK
Denmark
Prior art keywords
tablets containing
paroxetine hydrochloride
wet granulation
granulation process
preparation
Prior art date
Application number
DK02700190T
Other languages
English (en)
Inventor
Kristian Lund Henriksen
Niels Christian Felumb
Soren Bols Pedersen
Original Assignee
Gea Farmaceutisk Fabrik As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea Farmaceutisk Fabrik As filed Critical Gea Farmaceutisk Fabrik As
Application granted granted Critical
Publication of DK1363633T3 publication Critical patent/DK1363633T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK02700190T 2001-03-02 2002-03-01 Vådgranulerings-fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat DK1363633T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK200100341A DK200100341A (da) 2001-03-02 2001-03-02 Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat
PCT/DK2002/000134 WO2002069969A1 (en) 2001-03-02 2002-03-01 A process for the manufacture of pharmaceutical tablets containing paroxetine hydrochloride anhydrate

Publications (1)

Publication Number Publication Date
DK1363633T3 true DK1363633T3 (da) 2005-05-30

Family

ID=8160333

Family Applications (2)

Application Number Title Priority Date Filing Date
DK200100341A DK200100341A (da) 2001-03-02 2001-03-02 Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat
DK02700190T DK1363633T3 (da) 2001-03-02 2002-03-01 Vådgranulerings-fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK200100341A DK200100341A (da) 2001-03-02 2001-03-02 Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat

Country Status (11)

Country Link
US (1) US20040072912A1 (da)
EP (1) EP1363633B1 (da)
AT (1) ATE294580T1 (da)
AU (1) AU2002233182B2 (da)
CA (1) CA2439460A1 (da)
DE (1) DE60203997T2 (da)
DK (2) DK200100341A (da)
ES (1) ES2239707T3 (da)
NO (1) NO20033855D0 (da)
PT (1) PT1363633E (da)
WO (1) WO2002069969A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL162666A0 (en) * 2001-12-28 2005-11-20 Teva Pharma A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
US20040208932A1 (en) * 2003-04-17 2004-10-21 Ramachandran Thembalath Stabilized paroxetine hydrochloride formulation
EP1675574A2 (en) * 2003-10-08 2006-07-05 Ranbaxy Laboratories, Ltd. Pharmaceutical compositions of paroxetine containing microcrystalline cellulose, prepared by wet granulation
EP1841730A4 (en) * 2005-01-19 2010-10-27 Merck Frosst Canada Ltd CATHEPSIN K INHIBITORS AND ATHEROSCLEROSIS
AU2006274565B2 (en) * 2005-08-02 2012-05-17 Lupin Limited Novel controlled release compositions of selective serotonin reuptake inhibitors
CN113350350A (zh) * 2020-03-07 2021-09-07 齐鲁制药有限公司 一种含有盐酸培唑帕尼的药物组合物的制备方法
CN113730369B (zh) * 2020-05-27 2023-07-14 石药集团欧意药业有限公司 一种阿哌沙班片剂组合物及其制备方法
CN120076787A (zh) * 2022-10-28 2025-05-30 罗盖特公司 用于配制湿气敏感性活性成分的化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0149266B1 (en) * 1983-12-19 1988-05-18 Duphar International Research B.V Method of drying a solid and device therefor
US5856493A (en) * 1995-02-06 1999-01-05 Smithkline Beecham Corporation Process for making novel form of paroxeting hydrochloride anhydrate
GB9806312D0 (en) * 1998-03-24 1998-05-20 Smithkline Beecham Plc Novel formulations
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
US6660298B1 (en) * 2000-07-27 2003-12-09 Pentech Pharmaceuticals, Inc. Paroxetine tablets and capsules
CA2418038A1 (en) * 2000-08-28 2002-03-07 Synthon B.V. Paroxetine compositions and processes for making the same

Also Published As

Publication number Publication date
PT1363633E (pt) 2005-09-30
EP1363633B1 (en) 2005-05-04
CA2439460A1 (en) 2002-09-12
NO20033855L (no) 2003-09-01
DK200100341A (da) 2002-09-03
US20040072912A1 (en) 2004-04-15
WO2002069969A1 (en) 2002-09-12
ES2239707T3 (es) 2005-10-01
AU2002233182B2 (en) 2004-10-14
ATE294580T1 (de) 2005-05-15
EP1363633A1 (en) 2003-11-26
DE60203997T2 (de) 2006-02-23
DE60203997D1 (de) 2005-06-09
NO20033855D0 (no) 2003-09-01

Similar Documents

Publication Publication Date Title
EA200500405A1 (ru) Твёрдые фармацевтические лекарственные формы, включающие телмисартан
DK1076644T3 (da) N-Substituerede aminotetraliner som ligander for neutopeptid Y Y5-receptoren, der er nyttig til behandling af fedme og andre lidelser
ATE261300T1 (de) Direktverpressbare, ultrafeine acetaminophenzusammensetzungen und verfahren zu ihrer herstellung
BR0307409A (pt) Compostos de hidrazida de ácido 2-furanocarboxìlico, composições farmacêuticas contendo os mesmos e uso dos mesmos para preparação de um agente preventivo ou terapêutico
NO20011721D0 (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
RU2000123156A (ru) Быстро расщепляющаяся фармацевтическая лекарственная форма
JP2009537478A5 (da)
WO2003057150A3 (en) A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
DK1113787T3 (da) Agitationsuafhængige farmaceutiske multipelenhedsretardformuleringer og fremgangsmåde til deres fremstilling
DK1363633T3 (da) Vådgranulerings-fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat
RU2008106220A (ru) Гастроретентивные композиции и способ их изготовления
ATE441410T1 (de) Fenofibrattabletten
SE0102440D0 (sv) New compound
DK1165544T3 (da) Substituerede 1,4-dihydroindeno[1,2-c]pyrazoler som inhibitorer af tyrosinkinase
GR20010100377A (el) Φαρμακευτικη συνθεση περιεχουσα σιταλοπραμη
HRP20020181B1 (hr) Farmaceutski pripravci koji sadrže derivat benzamida kao aktivan sastojak
CY1112218T1 (el) Νεα παραγωγα ανταγωνιστες υποδοχεα βιτρονεκτινης, μεθοδος παρασκευης τους, η εφαρμογη τους ως φαρμακα και φαρμακευτικες συνθεσεις που τα περιεχουν
HRP20050342B1 (hr) Farmaceutska formulacija olanzapina
ATE260557T1 (de) Paraquatdichlorid enthaltendes wasserdispergierbare granulat und herstellungsmethode dafür
NO990665D0 (no) Granulater omfattende en vannl°selig forbindelse og cellulose
DE60110233D1 (de) Neue n-(2-phenyl-3-aminopropyl)naphtamide
ATE462414T1 (de) Irbesartan enthaltende feste zubereitung
WO2005034954A3 (en) Pharmaceutical compositions of paroxetine containing microcrystalline cellulose, prepared by wet granulation
NO20031030D0 (no) Nye krystaller av N-hydroksy-2(S)-metyl-5-etoksymetoksy-4(S)- [N-(4-fenoksyfenylkarbonyl)amino]pentanamid, fremgangsmåte for deresfremstilling og medisinerinneholdende krystallene som den aktive bestanddel
NO20001846L (no) Nye farmasøytisk aktive forbindelser, deres fremstilling og anvendelse som ECE-inhibitorer